Literature DB >> 25896507

Repression of SRF target genes is critical for Myc-dependent apoptosis of epithelial cells.

Katrin E Wiese1, Heidi M Haikala2, Björn von Eyss1, Elmar Wolf1, Cyril Esnault3, Andreas Rosenwald4, Richard Treisman3, Juha Klefström2, Martin Eilers5.   

Abstract

Oncogenic levels of Myc expression sensitize cells to multiple apoptotic stimuli, and this protects long-lived organisms from cancer development. How cells discriminate physiological from supraphysiological levels of Myc is largely unknown. Here, we show that induction of apoptosis by Myc in breast epithelial cells requires association of Myc with Miz1. Gene expression and ChIP-Sequencing experiments show that high levels of Myc invade target sites that lack consensus E-boxes in a complex with Miz1 and repress transcription. Myc/Miz1-repressed genes encode proteins involved in cell adhesion and migration and include several integrins. Promoters of repressed genes are enriched for binding sites of the serum-response factor (SRF). Restoring SRF activity antagonizes Myc repression of SRF target genes, attenuates Myc-induced apoptosis, and reverts a Myc-dependent decrease in Akt phosphorylation and activity, a well-characterized suppressor of Myc-induced apoptosis. We propose that high levels of Myc engage Miz1 in repressive DNA binding complexes and suppress an SRF-dependent transcriptional program that supports survival of epithelial cells.
© 2015 The Authors.

Entities:  

Keywords:  Akt; Miz1; Myc; apoptosis

Mesh:

Substances:

Year:  2015        PMID: 25896507      PMCID: PMC4474530          DOI: 10.15252/embj.201490467

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  79 in total

Review 1.  The role of MIZ-1 in MYC-dependent tumorigenesis.

Authors:  Katrin E Wiese; Susanne Walz; Björn von Eyss; Elmar Wolf; Dimitris Athineos; Owen Sansom; Martin Eilers
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

2.  Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors.

Authors:  Jessica K Altman; Antonella Sassano; Surinder Kaur; Heather Glaser; Barbara Kroczynska; Amanda J Redig; Suzanne Russo; Sharon Barr; Leonidas C Platanias
Journal:  Clin Cancer Res       Date:  2011-03-17       Impact factor: 12.531

3.  Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland.

Authors:  Xiaoyan Wang; Melissa Cunningham; Xiaoli Zhang; Sara Tokarz; Bryan Laraway; Megan Troxell; Rosalie C Sears
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

4.  Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression.

Authors:  Delin Chen; Ning Kon; Jiayun Zhong; Pingzhao Zhang; Long Yu; Wei Gu
Journal:  Mol Cell       Date:  2013-06-06       Impact factor: 17.970

5.  Miz1 is required to maintain autophagic flux.

Authors:  Elmar Wolf; Anneli Gebhardt; Daisuke Kawauchi; Susanne Walz; Björn von Eyss; Nicole Wagner; Christoph Renninger; Georg Krohne; Esther Asan; Martine F Roussel; Martin Eilers
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles.

Authors:  Susanne Walz; Francesca Lorenzin; Jennifer Morton; Katrin E Wiese; Björn von Eyss; Steffi Herold; Lukas Rycak; Hélène Dumay-Odelot; Saadia Karim; Marek Bartkuhn; Frederik Roels; Torsten Wüstefeld; Matthias Fischer; Martin Teichmann; Lars Zender; Chia-Lin Wei; Owen Sansom; Elmar Wolf; Martin Eilers
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962

7.  Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis.

Authors:  Arianna Sabò; Theresia R Kress; Mattia Pelizzola; Stefano de Pretis; Marcin M Gorski; Alessandra Tesi; Marco J Morelli; Pranami Bora; Mirko Doni; Alessandro Verrecchia; Claudia Tonelli; Giovanni Fagà; Valerio Bianchi; Alberto Ronchi; Diana Low; Heiko Müller; Ernesto Guccione; Stefano Campaner; Bruno Amati
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962

8.  Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase.

Authors:  Stefanie Peter; Jennyfer Bultinck; Kevin Myant; Laura A Jaenicke; Susanne Walz; Judith Müller; Michael Gmachl; Matthias Treu; Guido Boehmelt; Carsten P Ade; Werner Schmitz; Armin Wiegering; Christoph Otto; Nikita Popov; Owen Sansom; Norbert Kraut; Martin Eilers
Journal:  EMBO Mol Med       Date:  2014-12       Impact factor: 12.137

9.  BIM is the primary mediator of MYC-induced apoptosis in multiple solid tissues.

Authors:  Nathiya Muthalagu; Melissa R Junttila; Katrin E Wiese; Elmar Wolf; Jennifer Morton; Barbara Bauer; Gerard I Evan; Martin Eilers; Daniel J Murphy
Journal:  Cell Rep       Date:  2014-08-28       Impact factor: 9.423

10.  Rho-actin signaling to the MRTF coactivators dominates the immediate transcriptional response to serum in fibroblasts.

Authors:  Cyril Esnault; Aengus Stewart; Francesco Gualdrini; Phil East; Stuart Horswell; Nik Matthews; Richard Treisman
Journal:  Genes Dev       Date:  2014-04-14       Impact factor: 11.361

View more
  18 in total

Review 1.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

2.  MYC-induced apoptosis in mammary epithelial cells is associated with repression of lineage-specific gene signatures.

Authors:  Heidi M Haikala; Juha Klefström; Martin Eilers; Katrin E Wiese
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

3.  A conformational switch regulates the ubiquitin ligase HUWE1.

Authors:  Bodo Sander; Wenshan Xu; Martin Eilers; Nikita Popov; Sonja Lorenz
Journal:  Elife       Date:  2017-02-14       Impact factor: 8.140

Review 4.  Family matters: How MYC family oncogenes impact small cell lung cancer.

Authors:  Johannes Brägelmann; Stefanie Böhm; Matthew R Guthrie; Gurkan Mollaoglu; Trudy G Oliver; Martin L Sos
Journal:  Cell Cycle       Date:  2017-07-24       Impact factor: 4.534

Review 5.  MYC and tumor metabolism: chicken and egg.

Authors:  Francesca R Dejure; Martin Eilers
Journal:  EMBO J       Date:  2017-11-10       Impact factor: 11.598

6.  Myc requires RhoA/SRF to reprogram glutamine metabolism.

Authors:  Heidi M Haikala; Elsa Marques; Mikko Turunen; Juha Klefström
Journal:  Small GTPases       Date:  2016-09-20

7.  Serum Response Factor Protects Retinal Ganglion Cells Against High-Glucose Damage.

Authors:  Yan Cao; Liang Wang; Junhong Zhao; Hongbing Zhang; Ying Tian; Houcheng Liang; Qiang Ma
Journal:  J Mol Neurosci       Date:  2016-01-23       Impact factor: 3.444

Review 8.  Multi-phenotypic Role of Serum Response Factor in the Gastrointestinal System.

Authors:  Seungil Ro
Journal:  J Neurogastroenterol Motil       Date:  2016-04-30       Impact factor: 4.924

9.  Loss of serum response factor induces microRNA-mediated apoptosis in intestinal smooth muscle cells.

Authors:  C Park; M Y Lee; O J Slivano; P J Park; S Ha; R M Berent; R Fuchs; N C Collins; T J Yu; H Syn; J K Park; K Horiguchi; J M Miano; K M Sanders; S Ro
Journal:  Cell Death Dis       Date:  2015-12-03       Impact factor: 8.469

10.  MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation.

Authors:  Anton Shostak; Bianca Ruppert; Nati Ha; Philipp Bruns; Umut H Toprak; Roland Eils; Matthias Schlesner; Axel Diernfellner; Michael Brunner
Journal:  Nat Commun       Date:  2016-06-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.